Aikido pharma inc. executes licensing agreement for psilocybin for cancer applications

New york, jan. 6, 2021 /prnewswire/ -- aikido pharma inc. (nasdaq: aiki) ("aikido" or the "company") today announced that the company executed a patent license agreement for technology that covers the use of psilocybin for cancer applications. the technology is covered by four patent...
DOMH Ratings Summary
DOMH Quant Ranking